Co-development of assays and co-distribution of a fully integrated molecular platform due for launch in 2012 bioMérieux gains exclusive rights in microbiology bioMérieux takes equity stake in Biocartis
bioMérieux, Inc. Issues Urgent Product Correction for VITEK® 2 Gram Negative Susceptibility Cards Containing Piperacillin/Tazobactam
bioMérieux, Inc. on September 16, 2010, initiated a worldwide voluntary product correction of VITEK® 2 Gram Negative Susceptibility Cards containing the antibiotic Piperacillin/Tazobactam (TZP❷).
Business Review for the Nine Months Ended September 30, 2010
bioMérieux, a world leader in in vitro diagnostics, today released its business review for the nine months ended September 30, 2010.
bioMérieux Gains International Approval for its Automated "Next Day" Solution: VIDAS® Listeria Xpress
AOAC Official MethodsSM approval adds new level of confidence for food safety testing
2010 First-Half Review
The Board of Directors of bioMérieux, a global leader in the field of in vitro diagnostics, met on Friday, September 3, 2010 to approve the Group’s consolidated financial statements for the six months ended June 30, 2010. The meeting was chaired by Alain Mérieux and attended by the Statutory Auditors, who had performed a limited review of the financial statements.
bioMérieux to Host International Food Safety Symposium to Address Safety Issues Related to Food Supply
Ninth Annual Scientific Symposium to be held at the International Association for Food Protection’s (IAFP) 2010 Annual Meeting
Hyglos Honored with 2010 Food Safety Innovation Award for Technology Used in bioMérieux's VIDAS® UP E. Coli O157 (Including H7)
bioMérieux, a world leader in the field of in vitro diagnostics, and Hyglos GmbH, the leader in applied phage protein technology, today announced that a team of scientists who developed a new diagnostic tool for food microbiologists is the recipient of the 2010 Food Safety Innovation Award given by the International Association of Food Protection (IAFP). Visit www.biomerieux-usa.com or www.biomerieux-usa.com/iafp2010.
bioMérieux - First-Half 2010 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2010.
Lab Informatics Expert Joins bioMérieux
A world leader in in vitro diagnostics, bioMérieux today announced the appointment of Jacques L. Baudin as Vice President, Commercial Operations Information Technology.
bioMérieux's TEMPO® STA Assay Gains International Approvals for Food Safety Testing
tempo_sta_thumb16.jpg AFNOR/ISO and AOAC Research Institute validate performance of automated food safety solution. bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce that TEMPO® STA, an automated quality indicator test for the fast enumeration of Staphylococcus aureus in food products, has been approved by both the AFNOR Validation according to the ISO 16140 norm, and the AOAC Research Institute. The rigors of these third party validations provide food professionals with added assurance for high performance testing standards.